All In Biotech

Drug Trial Radar · NCT02055118

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

A Controlled, Randomized, Two-arm, Open-label, Assessor-blinded, Multicenter Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

58

Actual

Start

Mar 24, 2014

Primary completion

Sep 28, 2017

Study completion Sep 28, 2017

Sponsor

Lead sponsor
ShireTakeda (TAK)
Sponsor type
Industry
First posted
Feb 4, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Male only, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study HGT-HIT-094 is a multicenter study designed to determine the effect on clinical parameters of neurodevelopmental status of monthly IT administration of idursulfase-IT 10 mg for 12 months in pediatric patients with Hunter syndrome and cognitive impairment who have previously received and tolerated a minimum of 4 months of therapy with Elaprase.

Conditions

  • Hunter Syndrome

Interventions

  • idursulfase-ITBiological

    10mg

  • No IT treatmentOther

    Standard of Care

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Differential Ability Scales, Second Edition (DAS-II) General Conceptual Ability (GCA) Standard Score at Week 52Time frame: Baseline, Week 52

Locations

9 sites in 7 countries. Site status is shown where the registry gives one.

  • Children's Hospital and Research Center at Oakland

    Oakland, California

  • Ann & Robert H Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • University of North Carolina

    Chapel Hill, North Carolina

  • Women's and Children's Hospital, 72 King William Road

    North Adelaide, Australia

  • The Hospital for Sick Children

    Toronto, Ontario, Canada

  • Hôpital Femme Mère Enfant

    Bron, France

  • Instituto Nacional de Pediatría

    Coyoacán, Mexico City, Mexico

  • Hospital Infantil Universitario Niño Jesus

    Madrid, Spain

  • Royal Manchester Children's Hospital

    Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.